Medical Research

Mayo Clinic uses investigational targeted radiopharmaceutical theranostic for hepatocellular carcinoma in first-in-human clinical trial featured image
Cancer
Mayo Clinic uses investigational targeted radiopharmaceutical theranostic for hepatocellular carcinoma in first-in-human clinical trial

Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.   ROCHESTER, Minn. — Mayo Clinic[...]

Latest stories

Research
A step toward a cell-free solution for stress urinary incontinence
Susan Buckles
November 14, 2022
Science Saturday: Seeking a cellular therapy for chronic kidney disease featured image
Research
Science Saturday: Seeking a cellular therapy for chronic kidney disease
Susan Buckles
November 12, 2022
Multi-omics: A new model for identifying biomarkers to predict severe COVID-19 outcomes  featured image
Research
Multi-omics: A new model for identifying biomarkers to predict severe COVID-19 outcomes 
Mayo Clinic Staff
November 10, 2022
Beating the odds for a transplant featured image
Biotherapeutics
Beating the odds for a transplant
Susan Buckles
November 10, 2022
Study Suggests G9a Enzyme May Inhibit Intestinal Inflammation featured image
Research
Study Suggests G9a Enzyme May Inhibit Intestinal Inflammation
Gerri Kelly
November 9, 2022
A rare genetic cause for a common medical condition featured image
Research
A rare genetic cause for a common medical condition
Michael Clayton
November 9, 2022
First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD featured image
Research
First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD
Lynda De Widt
November 7, 2022
Science Saturday: Mayo Clinic study indicates U.S. rural counties have higher diabetes-related deaths featured image
Research
Science Saturday: Mayo Clinic study indicates U.S. rural counties have higher diabetes-related deaths
Colette Gallagher
November 5, 2022

Sign up to receive email notifications

Explore more topics

Sign up